Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, State University of New York, Buffalo, NY 14214-8033, USA.
Biopharm Drug Dispos. 2013 Mar;34(2):98-106. doi: 10.1002/bdd.1826. Epub 2012 Dec 3.
The effect of phenethyl isothiocyanate (PEITC), a component of cruciferous vegetables, on the initiation and progression of cancer was investigated in a chemically induced estrogen-dependent breast cancer model. Breast cancer was induced in female Sprague Dawley rats (8 weeks old) by the administration of N-methyl nitrosourea (NMU). Animals were administered 50 or 150 µmol/kg oral PEITC and monitored for tumor appearance for 18 weeks. The PEITC treatment prolonged the tumor-free survival time and decreased the tumor incidence and multiplicity. The time to the first palpable tumor was prolonged from 69 days in the control, to 84 and 88 days in the 50 and 150 µmol/kg PEITC-treated groups. The tumor incidence in the control, 50 µmol/kg, and 150 µmol/kg PEITC-treated groups was 56.6%, 25.0% and 17.2%, while the tumor multiplicity was 1.03, 0.25 and 0.21, respectively. Differences were statistically significant (p < 0.05) from the control, but there were no significant differences between the two dose levels. The intratumoral capillary density decreased from 4.21 ± 0.30 vessels per field in the controls to 2.46 ± 0.25 in the 50 µmol/kg and 2.36 ± 0.23 in the 150 µmol/kg PEITC-treated animals. These studies indicate that supplementation with PEITC prolongs the tumor-free survival, reduces tumor incidence and burden, and is chemoprotective in NMU-induced estrogen-dependent breast cancer in rats. For the first time, it is reported that PEITC has anti-angiogenic effects in a chemically induced breast cancer animal model, representing a potentially significant mechanism contributing to its chemopreventive activity.
苯乙基异硫氰酸酯(PEITC)是十字花科蔬菜的一种成分,它对化学诱导的雌激素依赖性乳腺癌模型中的癌症发生和进展的影响进行了研究。通过给予 N-甲基亚硝脲(NMU),诱导雌性 Sprague Dawley 大鼠(8 周龄)发生乳腺癌。动物给予 50 或 150 μmol/kg 口服 PEITC,并监测 18 周的肿瘤出现情况。PEITC 处理延长了无肿瘤存活时间,并降低了肿瘤发生率和多发性。从对照组的 69 天开始,第一可触及肿瘤的时间延长至 50 和 150 μmol/kg PEITC 处理组的 84 和 88 天。对照组、50 μmol/kg 和 150 μmol/kg PEITC 处理组的肿瘤发生率分别为 56.6%、25.0%和 17.2%,肿瘤多发性分别为 1.03、0.25 和 0.21。与对照组相比,差异具有统计学意义(p<0.05),但两个剂量水平之间没有显着差异。肿瘤内毛细血管密度从对照组的 4.21±0.30 个血管/视野降至 50 μmol/kg 的 2.46±0.25 和 150 μmol/kg 的 2.36±0.23。这些研究表明,PEITC 的补充延长了无肿瘤存活时间,降低了肿瘤发生率和负担,并在 NMU 诱导的大鼠雌激素依赖性乳腺癌中具有化学保护作用。首次报道 PEITC 在化学诱导的乳腺癌动物模型中具有抗血管生成作用,这代表了其化学预防活性的一个潜在重要机制。